101 related articles for article (PubMed ID: 8633135)
1. Abdominal iron deposition: metabolism, MR findings, and clinical importance.
Siegelman ES; Mitchell DG; Semelka RC
Radiology; 1996 Apr; 199(1):13-22. PubMed ID: 8633135
[No Abstract] [Full Text] [Related]
2. Ferumoxide-enhanced MRI of sideronecrosis superimposed on genetic hemochromatosis.
Aizenstein RI; Chen R; Sato K; Mihalov M; O'Neil HK
J Comput Assist Tomogr; 1999; 23(1):90-3. PubMed ID: 10050815
[TBL] [Abstract][Full Text] [Related]
3. [Focal intrahepatic siderosis, diagnostic pitfall, iatrogenic image].
Arteaga C; Raillat A; Salamand P; Debonne JM; Bonnet D; Martet G; Veuillet MO; Battini-Nouzille A; Briant JF
J Radiol; 1998 Feb; 79(2):157-8. PubMed ID: 9757234
[No Abstract] [Full Text] [Related]
4. Splenosis: superparamagnetic iron oxide-enhanced MR imaging.
Storm BL; Abbitt PL; Allen DA; Ros PR
AJR Am J Roentgenol; 1992 Aug; 159(2):333-5. PubMed ID: 1632350
[No Abstract] [Full Text] [Related]
5. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
6. Liver MR imaging with iron oxides: toward consensus and clinical practice.
Weissleder R
Radiology; 1994 Dec; 193(3):593-5. PubMed ID: 7972790
[No Abstract] [Full Text] [Related]
7. How can superparamagnetic iron oxides be used to monitor disease and treatment?
Unger EC
Radiology; 2003 Dec; 229(3):615-6. PubMed ID: 14657295
[No Abstract] [Full Text] [Related]
8. Iron oxides as MR imaging contrast agents.
Fahlvik AK; Klaveness J; Stark DD
J Magn Reson Imaging; 1993; 3(1):187-94. PubMed ID: 8428086
[No Abstract] [Full Text] [Related]
9. Can we monitor cell therapy with MR imaging at clinical field strength after systemic injection?
Clément O
Radiology; 2005 Jan; 234(1):3. PubMed ID: 15618365
[No Abstract] [Full Text] [Related]
10. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
11. Target-specific superparamagnetic MR contrast agents.
Weissleder R
Magn Reson Med; 1991 Dec; 22(2):209-12; discussion 213-5. PubMed ID: 1812348
[No Abstract] [Full Text] [Related]
12. Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.
Daldrup-Link HE; Kaiser A; Link TM; Settles M; Helbich T; Werner M; Roberts TP; Rummeny EJ
Acad Radiol; 2002 Aug; 9 Suppl 2():S343-7. PubMed ID: 12188270
[No Abstract] [Full Text] [Related]
13. Can MR imaging be used to track delivery of intravascularly administered stem cells?
Mahmood U
Radiology; 2004 Dec; 233(3):625-6. PubMed ID: 15564396
[No Abstract] [Full Text] [Related]
14. SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging.
Hamm B; Staks T; Taupitz M
Invest Radiol; 1994 Jun; 29 Suppl 2():S87-9. PubMed ID: 7928280
[No Abstract] [Full Text] [Related]
15. Patterns of USPIO deposition in murine atherosclerosis.
Klug G; Bauer L; Bauer WR
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):E157; author reply E158-9. PubMed ID: 18716317
[No Abstract] [Full Text] [Related]
16. USPIO-enhanced MRI of neuroinflammation at the sub-acute stage of ischemic stroke: preliminary data.
Cho TH; Nighoghossian N; Wiart M; Desestret V; Cakmak S; Berthezène Y; Derex L; Louis-Tisserand G; Honnorat J; Froment JC; Hermier M
Cerebrovasc Dis; 2007; 24(6):544-6. PubMed ID: 18042981
[No Abstract] [Full Text] [Related]
17. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
[TBL] [Abstract][Full Text] [Related]
18. Sensitive physiologic imaging with contrast-enhanced magnetic resonance imaging.
Litt L
Anesthesiology; 1998 Apr; 88(4):847-50. PubMed ID: 9579490
[No Abstract] [Full Text] [Related]
19. Imaging of rheumatoid arthritis: can MR imaging be used to monitor cellular response of disease?
Mosher TJ
Radiology; 2004 Oct; 233(1):1-2. PubMed ID: 15454613
[No Abstract] [Full Text] [Related]
20. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
